(Ivanhoe Newswire) -- It has been well-known that high levels of high-density lipoprotein (HDL) cholesterol, the “good” kind, are associated with a lower risk of heart disease. Recent studies have asked if pharmacologic increases in HDL cholesterol levels are beneficial to the patient. A new study shows that a different metric, a measure of HDL function called cholesterol efflux capacity, is more closely associated with protection against heart disease than HDL cholesterol levels themselves.
